Market cap
₹253 Cr
Revenue (TTM)
₹-- Cr
P/E Ratio
677
P/B Ratio
--
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -- | 53.97 | 15.62 | 12.21 |
| Net Profit | -- | -- | -76.16 | -61.62 | -47.50 |
| EPS | -- | -- | -76.16 | -61.62 | -47.50 |
| Book Value | -- | -- | 0.03 | 1.93 | 2.06 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -12.50 | -- | -- | -- |
| Net Margin
| -- | 8.64 | -- | -- | -- |
| Return on equity
| 2.03 | 2.40 | 0.24 | 1.03 | 4.81 |
| Return on Capital
| 2.87 | 3.56 | 0.27 | 1.92 | 6.43 |
| Return on Assets
| 2.02 | 2.38 | 0.25 | 1.03 | 4.78 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
0.27
Lower than Peers by 17.27
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
0.27
|
1.92
|
6.43
|
6.05
|
3.11
|
|
Peer Median
|
17.54
|
17.47
|
14.92
|
7.28
|
--
|
ROE
0.24
Lower than Peers by 13.01
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
0.24
|
1.03
|
4.81
|
4.69
|
1.24
|
|
Peer Median
|
13.25
|
13.14
|
17.97
|
10.43
|
--
|
ROA
0.25
Lower than Peers by 7.88
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
0.25
|
1.03
|
4.78
|
4.66
|
1.17
|
|
Peer Median
|
8.13
|
9.05
|
8.19
|
3.45
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
-7.22
|
-17.78
|
|
Peer Median
|
8.63
|
8.76
|
9.72
|
13.50
|
--
|
Net Margin
23.58
Higher than Peers by 17.00
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
23.58
|
28.68
|
62.51
|
14.10
|
3.19
|
|
Peer Median
|
6.57
|
6.20
|
9.99
|
4.68
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
18.55
|
5.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
-100.00
|
-21.64
|
-22.05
|
|
Peer Median
|
11.86
|
21.47
|
35.85
|
42.06
|
--
|
EBIT Growth
53.97
Higher than Peers by 41.92
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
53.97
|
-36.07
|
27.43
|
68.17
|
-52.71
|
|
Peer Median
|
12.05
|
30.42
|
3.61
|
153.31
|
--
|
Net Profit Growth
-76.16
Lower than Peers by 77.51
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
-76.16
|
-77.97
|
7.63
|
286.52
|
-81.74
|
|
Peer Median
|
1.34
|
62.37
|
-0.47
|
389.91
|
--
|
EPS Growth
-76.16
Lower than Peers by 85.05
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
-76.16
|
-77.97
|
7.63
|
286.47
|
-81.73
|
|
Peer Median
|
8.89
|
29.81
|
5.88
|
200.00
|
--
|
Book Value Growth
0.03
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
0.03
|
0.87
|
4.94
|
4.80
|
-0.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.32
|
0.30
|
0.36
|
0.27
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
360.48
Higher than Peers by 359.26
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
360.48
|
393.84
|
68.73
|
61.75
|
53.83
|
|
Peer Median
|
1.23
|
1.21
|
1.20
|
1.38
|
--
|
Quick Ratio
360.48
Higher than Peers by 359.65
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
360.48
|
393.84
|
68.73
|
61.75
|
53.83
|
|
Peer Median
|
0.83
|
0.78
|
0.78
|
0.85
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
3.55
|
--
|
455.06
|
620.76
|
|
Peer Median
|
8.72
|
13.82
|
12.41
|
10.23
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
1.06
|
35.87
|
|
Peer Median
|
14.88
|
15.84
|
13.34
|
11.63
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
0.25
|
0.31
|
|
Peer Median
|
1.00
|
1.34
|
0.89
|
0.91
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
85.47
|
128.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
0.52
|
5.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
84.95
|
122.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
472.63
Higher than Peers by 419.82
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
472.63
|
140.66
|
16.61
|
26.13
|
42.52
|
|
Peer Median
|
52.81
|
68.13
|
42.40
|
31.46
|
--
|
Price / Book Value
1.16
Lower than Peers by 5.60
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
1.16
|
1.44
|
0.78
|
1.20
|
0.53
|
|
Peer Median
|
6.75
|
10.86
|
5.40
|
5.19
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.55
|
0.39
|
0.80
|
0.80
|
--
|
EV/EBITDA
429.97
Higher than Peers by 390.65
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
429.97
|
75.05
|
12.27
|
20.22
|
84.09
|
|
Peer Median
|
39.31
|
71.18
|
35.62
|
49.84
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
ASL
|
--
|
--
|
--
|
40
|
17
|
|
Peer Median
|
62,764
|
81,800
|
50,246
|
41,338
|
--
|